Home › Hidradenitis Suppurativa › Illinois
Pag-aaral pangklinika para sa Hidradenitis Suppurativa sa Illinois
6 pag-aaral para sa Hidradenitis Suppurativa ang naghahanap ng mga kalahok sa mga site sa Illinois.
Mga Lungsod sa Illinois
Opisyal na teksto ng pag-aaral (English)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Endeavor Health, Glenview
- Dundee Dermatology, West Dundee
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Chicago
Nagre-recruitPhase 2
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- NorthShore University Health System - Endeavor Health Medical Group - Skokie - Woods Drive- Site Number : 8400019, Skokie
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US125, Chicago
- Investigative Site US093, Chicago
- Investigative Site US039, West Dundee
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06855498Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Endeavor Health Medical Group, Skokie
Nagre-recruitPhase 2
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07213973A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Northwestern University, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07123038Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.